Phenotypic correlations in FTDP-17

被引:174
|
作者
Reed, LA [1 ]
Wszolek, ZK
Hutton, M
机构
[1] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA
[2] Mayo Clin, Jacksonville, FL 32224 USA
关键词
frontotemporal dementia; parkinsonism; tau; FTDP-17; hereditary neurodegenerative disease; alternative splicing;
D O I
10.1016/S0197-4580(00)00202-5
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Frontotemporal dementias with parkinsonism linked to chromosome 17 (FTDP-17) are hereditary tauopathies affecting at least 50 known kindred worldwide. Most kindred present with severe behavioral or psychiatric manifestations progressing to dementia, while some kindred first manifest a parkinsonian-plus syndrome. Nine missense mutations, one deletion mutation, and two transition mutations not altering the encoded amino acid, have been described in or near the microtubule-binding domains within exons 9, 10, 12, and 13. In addition, five different intronic mutations have been reported in the 5' splice-site of the alternatively spliced exon 10. Missense mutations affecting constitutively expressed exons affect all six major tan isoforms and result in neurofibrillary tangles similar to those present in secondary tauopathies, such as Alzheimer's disease. In contrast, mutations that affect the alternatively spliced exon 10 or its: 5' splice regulatory region alter the ratio of the tau isoforms incorporated into the tangles acid result in filamentous inclusions resembling those seen in the primary tauopathies, such as progressive supranuclear palsy, corticobasal degeneration, and Pick's disease. The severity and heterogeneity of the clinicomorphologic phenotype may, in part, reflect the diversity in the primary molecular mechanisms of disease in FTDP-17. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:89 / 107
页数:19
相关论文
共 50 条
  • [41] CLINICAL CHARACTERISTICS AND POSSIBLE MECHANISMS UNDERLYING BEHAVIORAL AND PERSONALITY CHANGES IN FTDP-17
    Harciarek, Michal
    Sitek, Emilia J.
    Narozanska, Ewa
    Konieczna, Seweryna
    Wieczorek, Dariusz
    Brockhuis, Bogna
    Lass, Piotr
    Dubaniewicz-Wybieralska, Miroslawa
    Barcikowska, Maria
    Slawek, Jaroslaw
    ACTA NEUROPSYCHOLOGICA, 2013, 11 (02) : 161 - 179
  • [42] Changes in the rate of clinical and radiologic progression in FTDP-17 associated with lithium administration
    Boeve, B
    Shiung, M
    Jack, C
    Knopman, D
    Smith, G
    Ivnik, R
    Hutton, M
    Tremont-Lukats, I
    Waclawik, A
    Murrell, J
    Koppikar, V
    Ghetti, B
    Petersen, R
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S279 - S279
  • [43] Familial frontotemporal dementia and parkinsonism (FTDP-17) - A consensus on clinical diagnostic criteria
    Wszolek, ZK
    Tsuboi, Y
    MAPPING THE PROGRESS OF ALZHEIMER'S AND PARKINSON'S DISEASE, 2002, 51 : 517 - 522
  • [44] In vivo analysis of wild-type and FTDP-17 tau transgenic mice
    Götz, J
    Barmettler, R
    Ferrari, A
    Goedert, M
    Probst, A
    Nitsch, RM
    MOLECULAR BASIS OF DEMENTIA, 2000, 920 : 126 - 133
  • [45] FTDP-17 Tau Mutations Induce Distinct Effects on Aggregation and Microtubule Interactions
    Combs, Benjamin
    Gamblin, T. Chris
    BIOCHEMISTRY, 2012, 51 (43) : 8597 - 8607
  • [46] FTDP-17 tau mutations decrease the susceptibility of tau to calpain I digestion
    Yen, S
    Easson, C
    Nacharaju, P
    Hutton, M
    Yen, SH
    FEBS LETTERS, 1999, 461 (1-2) : 91 - 95
  • [47] Tau pathology in frontotemporal dementia with parkinsonism (FTDP-17) - an Australian pedigree.
    McLean, CA
    Maher, F
    Dark, F
    Masters, CL
    Tannenberg, AE
    BRAIN PATHOLOGY, 2000, 10 (04) : 529 - 529
  • [48] Altered expression of brain acetylcholinesterase in FTDP-17 human tau transgenic mice
    Silveyra, Maria-Ximena
    Garcia-Ayllon, Maria-Salud
    Gomez de Barreda, Elena
    Small, David H.
    Martinez, Salvador
    Avila, Jesus
    Saez-Valero, Javier
    NEUROBIOLOGY OF AGING, 2012, 33 (03)
  • [49] Changes in the rate of clinical and radiologic progression in FTDP-17 associated with lithium administration
    Boeve, BF
    Shiung, MM
    Jack, CR
    Knopman, DS
    Smith, GE
    Hutton, M
    Murrell, J
    Koppikar, V
    Ghetti, B
    Petersen, RC
    NEUROLOGY, 2006, 66 (05) : A57 - A57
  • [50] FTDP-17 mutations compromise the ability of Tau to regulate microtubule dynamics in cells
    Bunker, JM
    Kamath, K
    Wilson, L
    Jordan, MA
    Feinstein, SC
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (17) : 11856 - 11863